Search Within

Genitourinary Oncology Service

  1. "BMC Cancer"
Formats
  1. Journal Article (8)
Groups
  1. Department of Medicine (8)
  2. Solid Tumor Oncology Division (8)
  3. Hematologic Malignancies, Division of (1)
  4. Hematology-Oncology Fellows (1)
  5. Weinberg Fellows (1)
People
  1. Robert Motzer (4)
  2. Gopakumar Iyer (1)
  3. Jonathan Rosenberg (1)
  4. Michael Morris (1)
  5. Min Yuen Teo (1)
  6. Richard Bambury (1)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2021 (2)
  4. 2018 (2)
  5. 2015 (1)
  6. 2012 (1)
Publications
  1. BMC Cancer (8)
Publishers
  1. Biomed Central Ltd (8)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized, open-label, phase 3 trial of pembrolizumab plus epacadostat versus sunitinib or pazopanib as first-line treatment for metastatic renal cell carcinoma (KEYNOTE-679/ECHO-302)
    Journal Article

    Lara, P. N.; Villanueva, L.; Ibanez, C.; Erman, M.; Lee, J. L.; Heinrich, D.; Lipatov, O. N.; Gedye, C.; Gokmen, E.; Acevedo, A.; more...
    BMC Cancer (2024)

    Fulltext@MSK | Save
  • Relationship between insurance status and interhospital transfers among cancer patients in the United States
    Journal Article

    Rubens, M.; Ramamoorthy, V.; Saxena, A.; Appunni, S.; Sundil, S.; Veledar, E.; McGranaghan, P.; Tonse, R.; Fitz, S. J. T.; Chuong, M. D.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma
    Journal Article

    Powles, T.; Choueiri, T. K.; Motzer, R. J.; Jonasch, E.; Pal, S.; Tannir, N. M.; Signoretti, S.; Kaldate, R.; Scheffold, C.; Wang, E.; more...
    BMC Cancer (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)
    Journal Article

    Grivas, P.; Loriot, Y.; Morales-Barrera, R.; Teo, M. Y.; Zakharia, Y.; Feyerabend, S.; Vogelzang, N. J.; Grande, E.; Adra, N.; Alva, A.; more...
    BMC Cancer (2021)

    Fulltext@MSK | Save
  • The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: A study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD
    Journal Article

    Pacyna, J. E.; Kim, S.; Yost, K.; Sedlacek, H.; Petereit, D.; Kaur, J.; Rapkin, B.; Grubb, R.; Paskett, E.; Chang, G. J.; more...
    BMC Cancer (2018)

    Fulltext@MSK | Save
  • RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis
    Journal Article

    Yang, L.; Alyasova, A.; Ye, D.; Ridolfi, A.; Dezzani, L.; Motzer, R. J.
    BMC Cancer (2018)

    Fulltext@MSK | Save
  • DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors
    Journal Article

    Bambury, R. M.; Bhatt, A. S.; Riester, M.; Pedamallu, C. S.; Duke, F.; Bellmunt, J.; Stack, E. C.; Werner, L.; Park, R.; Iyer, G.; more...
    BMC Cancer (2015)

    Fulltext@MSK | Save
  • Dynamic tumor modeling of the dose-response relationship for everolimus in metastatic renal cell carcinoma using data from the phase 3 RECORD-1 trial
    Journal Article

    Stein, A.; Wang, W.; Carter, A. A.; Chiparus, O.; Hollaender, N.; Kim, H.; Motzer, R. J.; Sarr, C.
    BMC Cancer (2012)

    Fulltext@MSK | Save